Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Phase 3

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT01259895Completed

Effects of Time of Sleep Restriction in Obesity

Role: collaborator

NCT01850095Not ApplicableUnknown

The Influence of Peripheral Androgen Conversion at Women Adult Acne

Role: collaborator

NCT01336556Not ApplicableUnknown

Titration of Continuous Positive Airway Pressure Could Predict Success of Oral Appliance to Treat Sleep Apnea

Role: lead

NCT01455077Unknown

Portable Monitoring Device for the Diagnosis of Sleep Apnea in Obese Patients

Role: lead

NCT01392339Not ApplicableUnknown

Obstructive Sleep Apnea and Genes Expression

Role: lead

NCT01315535Unknown

Fast Titration of Oral Appliance at Obstructive Sleep Apnea Syndrome (OSAS) Treatment

Role: lead

NCT01211769Phase 3Completed

Effects of Omegas 3 and 6 on Alcohol Dependence

Role: collaborator

NCT01113203Not ApplicableCompleted

Chronic and Acute Effects of Resistance Exercise on Older Subjects' Blood Pressure

Role: collaborator

NCT00915642Unknown

Overnight Weight Loss and Sleep Structure

Role: lead

NCT00912457Phase 4Unknown

Donepezil Treatment for Sleep Apnea Patients

Role: lead

NCT00768625Unknown

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Role: lead

NCT00480870Phase 4Completed

The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients

Role: lead

All 12 trials loaded